178 related articles for article (PubMed ID: 35928985)
1. The RiVUR Study Outcomes and Implications on the Management of Vesicoureteral Reflux.
Damm T; Mathews R
Arch Nephrol Ren Stud; 2022; 2(1):1-5. PubMed ID: 35928985
[TBL] [Abstract][Full Text] [Related]
2. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.
Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605
[TBL] [Abstract][Full Text] [Related]
3. The role of voiding cystourethrography in the investigation of children with urinary tract infections.
Lee LC; Lorenzo AJ; Koyle MA
Can Urol Assoc J; 2016; 10(5-6):210-214. PubMed ID: 27713802
[TBL] [Abstract][Full Text] [Related]
4. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.
Carpenter MA; Hoberman A; Mattoo TK; Mathews R; Keren R; Chesney RW; Moxey-Mims M; Greenfield SP;
Pediatrics; 2013 Jul; 132(1):e34-45. PubMed ID: 23753091
[TBL] [Abstract][Full Text] [Related]
5. The RIVUR trial: a factual interpretation of our data.
Mattoo TK; Carpenter MA; Moxey-Mims M; Chesney RW;
Pediatr Nephrol; 2015 May; 30(5):707-12. PubMed ID: 25558811
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial prophylaxis for vesicoureteral reflux: which subgroups of children benefit the most?
Zhao B; Ivanova A; Shaikh N
Res Sq; 2023 Aug; ():. PubMed ID: 37693511
[TBL] [Abstract][Full Text] [Related]
7. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.
Mathews R; Mattoo TK
Adv Chronic Kidney Dis; 2015 Jul; 22(4):325-30. PubMed ID: 26088078
[TBL] [Abstract][Full Text] [Related]
8. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography.
Schaeffer AJ; Greenfield SP; Ivanova A; Cui G; Zerin JM; Chow JS; Hoberman A; Mathews RI; Mattoo TK; Carpenter MA; Moxey-Mims M; Chesney RW; Nelson CP
J Pediatr Urol; 2017 Apr; 13(2):192-198. PubMed ID: 27666144
[TBL] [Abstract][Full Text] [Related]
9. Top-Down versus Bottom-Up Approach in Children Presenting with Urinary Tract Infection: Comparative Effectiveness Analysis Using RIVUR and CUTIE Data.
Scott Wang HH; Cahill D; Panagides J; Logvinenko T; Nelson C
J Urol; 2021 Nov; 206(5):1284-1290. PubMed ID: 34181468
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial prophylaxis for vesicoureteral reflux: which subgroups of children benefit the most?
Zhao B; Ivanova A; Shaikh N
Pediatr Nephrol; 2024 Jun; 39(6):1859-1863. PubMed ID: 38244067
[TBL] [Abstract][Full Text] [Related]
11. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months.
; Roberts KB
Pediatrics; 2011 Sep; 128(3):595-610. PubMed ID: 21873693
[TBL] [Abstract][Full Text] [Related]
12. Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study.
Mathews R; Carpenter M; Chesney R; Hoberman A; Keren R; Mattoo T; Moxey-Mims M; Nyberg L; Greenfield S
J Pediatr Urol; 2009 Oct; 5(5):336-41. PubMed ID: 19570724
[TBL] [Abstract][Full Text] [Related]
13. Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux.
Arlen AM; Alexander SE; Wald M; Cooper CS
J Pediatr Urol; 2016 Oct; 12(5):288.e1-288.e5. PubMed ID: 27072485
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Resistance and Urinary Tract Infection Recurrence.
Nelson CP; Hoberman A; Shaikh N; Keren R; Mathews R; Greenfield SP; Mattoo TK; Gotman N; Ivanova A; Moxey-Mims M; Carpenter MA; Chesney RW
Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26969273
[TBL] [Abstract][Full Text] [Related]
15. The RIVUR study: a review of its findings.
Cara-Fuentes G; Gupta N; Garin EH
Pediatr Nephrol; 2015 May; 30(5):703-6. PubMed ID: 25503325
[TBL] [Abstract][Full Text] [Related]
16. Asian guidelines for urinary tract infection in children.
Yang SS; Tsai JD; Kanematsu A; Han CH
J Infect Chemother; 2021 Nov; 27(11):1543-1554. PubMed ID: 34391623
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
[TBL] [Abstract][Full Text] [Related]
18. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.
Stenbäck A; Olafsdottir T; Sköldenberg E; Barker G; Stenberg A; Läckgren G
J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615
[TBL] [Abstract][Full Text] [Related]
19. Delayed upper tract drainage on voiding cystourethrogram may not be associated with increased risk of urinary tract infection in children with vesicoureteral reflux.
Garcia-Roig M; Arlen AM; Huang JH; Filimon E; Leong T; Kirsch AJ
J Pediatr Urol; 2016 Oct; 12(5):312.e1-312.e6. PubMed ID: 27492248
[TBL] [Abstract][Full Text] [Related]
20. Consequences of following the new American Academy of Pediatrics guidelines for imaging children with urinary tract infection.
Ristola MT; Hurme T
Scand J Urol; 2015; 49(5):419-23. PubMed ID: 25660228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
